Intra-Cellular Therapies (ITCI) Reports Q1 Loss of $0.63/Share

May 8, 2019 7:40 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.63), versus ($0.65) reported last year.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

The Children's Investment Fund (TCI), Earnings